news
Comparative Efficacy and Safety of Elagolix Versus Dienogest in Moderate-to-Severe Endometriosis Pain: Insights from a Phase III Multicentric Trial
This phase III study demonstrates that elagolix is non-inferior to dienogest in reducing moderate-to-severe endometriosis pain, with comparable safety and tolerability profiles, supporting elagolix as a valuable treatment option.
